Related Experiment Video
Updated: Nov 30, 2025

03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
744
Improving target assessment in biomedical research: the GOT-IT recommendations
Christoph H Emmerich1, Lorena Martinez Gamboa2,3, Martine C J Hofmann4
1PAASP GmbH, Heidelberg, Germany. christoph.emmerich@paasp.net.
Nature Reviews. Drug Discovery
|November 17, 2020
Summary
Academic research identifies drug targets, but needs industry collaboration for clinical trials. The GOT-IT framework guides academics in target assessment for efficient drug development and industry partnerships.
Area of Science:
- Biomedical Research
- Drug Discovery
- Translational Science
Background:
- Academic research is crucial for identifying novel drug targets and understanding disease associations.
- Transitioning academic discoveries to clinical drug development requires industry involvement and rigorous target assessment.
Purpose of the Study:
- To provide recommendations for academic scientists and funders to prioritize target assessment activities.
- To define a critical path for academic research to achieve scientific, licensing, and clinical development goals.
- To enhance the efficiency and robustness of translational research and academia-industry collaboration.
Main Methods:
- Development of the GOT-IT (Goals, Opportunities, Targets, and Implementation Tactics) framework.
- Creation of guiding questions for key areas of target assessment.
- Focus on safety, druggability, assayability, and therapeutic differentiation.
Main Results:
- The GOT-IT framework offers a structured approach to target assessment for academic researchers.
- It highlights critical factors for advancing drug targets from discovery to potential clinical development.
- The framework aims to improve the translation of academic findings into industry-relevant drug candidates.
Conclusions:
- The GOT-IT framework supports academic scientists in navigating the complexities of drug target validation and development.
- Implementing the framework can accelerate the progression of academic research towards industry partnerships and clinical programs.
- Enhanced target assessment is key to fostering successful academia-industry collaborations in drug discovery.
Related Concept Videos
Improving Translational Accuracy
3.4K
3.4K
Improving Translational Accuracy
12.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
12.9K
Targets for Drug Action: Overview
9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K

